심전도(ECG) 원격 측정 장치 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)
ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT, and Others), Application, End User, and Region 2025-2033
상품코드:1702055
리서치사:IMARC
발행일:2025년 04월
페이지 정보:영문 137 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
심전도(ECG) 원격 측정 장치 시장 세계 시장 규모는 2024년 61억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 112억 달러에 달하고, 2025-2033년 연평균 성장률(CAGR)은 6.93%를 보일 것으로 예측했습니다.
심전도(ECG) 원격 측정 장치는 심혈관 질환(CVD)이 의심되는 환자의 신속한 심전도 모니터링을 가능하게 합니다. 심전계는 심장 조직에서 발생하는 전기적 임펄스를 감지하고 이를 파형으로 변환합니다. 심전계는 병원과 재택치료 서비스에서 광범위하게 사용되고 있습니다. 현재 술과 담배, 비만, 운동 부족으로 인해 심장마비, 뇌졸중 등 CVD의 유병률이 증가함에 따라 심전도(ECG) 원격 측정 장치에 대한 수요가 전 세계적으로 증가하고 있습니다.
심전도(ECG) 원격 측정 장치 시장 동향 :
심전도(ECG) 원격 측정 장치는 심박수가 비정상적인 부정맥을 진단하고 치료하는 데 사용됩니다. 이 장치는 심장 리듬의 변동에 대한 정보를 제공하여 의사가 필요한 조치를 취할 수 있도록 도와줍니다. 이 외에도 심전도(ECG) 원격 측정 장치에는 관상동맥 질환(CAD) 및 울혈성 심부전(CHF)과 같은 상태를 식별하는 데 사용되는 휴식기 심전도(resting ECG)가 있습니다. 이는 헬스케어 산업의 번영과 함께 시장 성장을 강화하고 있습니다. 이 외에도 심전도계, 디지털 온도계, 자동 혈압계, 혈당 측정기, 체지방 측정기 등 건강 모니터링 기기의 주거 분야에서의 활용이 크게 증가하고 있습니다. 이러한 기기는 환자나 간병인이 최소한의 교육으로 조작할 수 있습니다. 또한 코로나19는 심혈관계에 영향을 미쳐 심근 손상과 심장 및 내피 기능 장애를 유발할 수 있습니다. 이는 노인 인구 증가와 함께 전 세계적으로 심전도(ECG) 원격 측정 장치에 대한 수요를 촉진하고 있습니다. 다른 요인으로는 기술 발전과 대중의 심혈관 건강에 대한 인식이 높아짐에 따라 향후 몇 년 동안 전체 매출과 수익성에 긍정적인 영향을 미칠 것으로 예측됩니다.
The global ECG telemetry devices market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.93% during 2025-2033.
Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.
ECG Telemetry Devices Market Trends:
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.
Key Market Segmentation:
Breakup by Product:
Event Monitoring and MCT (Mobile Cardiac Telemetry)
Others
Breakup by Application:
Arrhythmias
Myocardial Ischemia and Infarction
Pacemaker Monitoring
Others
Breakup by End User:
Hospitals
Home Healthcare
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).
Key Questions Answered in This Report
1.What was the size of the global ECG telemetry devices market in 2024?
2.What is the expected growth rate of the global ECG telemetry devices market during 2025-2033?
3.What has been the impact of COVID-19 on the global ECG telemetry devices market?
4.What are the key factors driving the global ECG telemetry devices market?
5.What is the breakup of the global ECG telemetry devices market based on the product?
6.What is the breakup of the global ECG telemetry devices market based on the application?
7.What are the key regions in the global ECG telemetry devices market?
8.Who are the key players/companies in the global ECG telemetry devices market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global ECG Telemetry Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Event Monitoring and MCT (Mobile Cardiac Telemetry)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Others
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Arrhythmias
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Myocardial Ischemia and Infarction
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Pacemaker Monitoring
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Healthcare
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Aerotel Medical Systems (1998) Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Compumed Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Hill-Rom Holdings Inc. (Baxter International Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 iRhythm Technologies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Koninklijke Philips N.V.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Medicalgorithmics S.A.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Nihon Kohden Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Preventice Solutions Inc. (Boston Scientific Corporation)
